Image

China Gender-affirming Hormone Therapy Study

China Gender-affirming Hormone Therapy Study

Recruiting
18-40 years
All
Phase N/A

Powered by AI

Overview

Data about transgender medical care, especially the gender-affirming hormone therapy (GAHT) is extremely insufficient in China. Few evidence exists in the physical and psychological effects of the hormonal treatment in Chinese transgender population. CGAHT is designed to describe the social and mental condition of transgender people who are seeking for formal GAHT, and to investigate the physical and psychological effects of GAHT on this population in China.

Description

CGAHT will be conducted in one of the main transgender medical centers in Chinese mainland. Participants who are seeking for the start of GAHT will be enrolled from clinical visitors. Before GAHT, participants will be interviewed with questionaries about their life experience, gender identity and social economic conditions. Evaluations on mental and physical health will be performed at baseline and during the GAHT. Participants will be followed up to 12 months. GAHT will be given to transgender people according to the protocol recommended by the international guideline (doi: 10.1210/jc.2017-01658) .

Eligibility

Inclusion Criteria:

  • Transgender men and women
  • Meet criteria of Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) for gender dysphoria
  • Aged between 18 to 40 years
  • People desire to start the GAHT
  • No previous history of gender-affirming interventions
  • Having full ability to make informed consent
  • Dextromanual

Exclusion Criteria:

  • Disorders of sex development
  • Who has fertility demand but have not made fertility preservation
  • With contradictions of GAHT
  • Comorbid diseases are not under control
  • Alcohol or drug abuse
  • Hormonal and chromosomal disorders
  • History of gender affirming surgery
  • Current psychiatric disorders
  • History of brain trauma or neurological pathologies
  • Current use of medications with psychotropic effects within two weeks (antipsychotic or antiepileptic agents, lithium, benzodiazepines or opioid analgesics)
  • Claustrophobia
  • Implanted metal and medical devices (pacemakers, ceramic teeth, etc.),
  • Tattoos or eyebrow tattooing (heavy metal dye)

Study details
    Transgender
    Gender Incongruence

NCT05318755

Peking University Third Hospital

27 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.